Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Breast Cancer
Erschienen in: Breast Cancer 5/2014

01.09.2014 | Original Article

Procedures for location of non-palpable breast lesions: a systematic review for the radiologist

verfasst von: Roberta Fusco, Antonella Petrillo, Orlando Catalano, Mario Sansone, Vincenza Granata, Salvatore Filice, Massimiliano D’Aiuto, Quentin Pankhurst, Michael Douek

Erschienen in: Breast Cancer | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Accurate location of small breast lesions is mandatory for proper surgical management. The purpose of this article is systematically review procedures used to locate non-palpable breast lesions, including a description of the current status, advantages, and disadvantages for each technique. A total of 47 articles were finally included: 7 articles for the wire location technique, 5 articles for the radioguided location technique, 13 articles that compare wire location with radioguided location, 3 articles for the carbon location technique, 2 articles that compare wire location with carbon location, and 17 articles for the clip location technique. The success of location and the clear margin are reported for each location technique and for the separate articles included; clip migration shift, also, is reported for the clip location technique. Odds ratio with related 95 % confidence intervals were also calculated for successful location. Comparative analysis or meta-analysis for all the different breast lesion location techniques is missing. Prospective investigations and randomized investigations for homogeneous populations are still needed to determine which is the most cost-effective modality among those used to date.
Literatur
1.
Ernst MF, Avenarius JKA, Schuur KH, et al. Wire localization of non-palpable breast lesions: out of date? Breast. 2002;11:408–13.PubMedCrossRef
2.
Chu TYC, Lui CY, Hung WK, et al. Localisation of occult breast lesion: a comparative analysis of hookwire and radioguided procedures. Hong Kong Med J. 2010;16:367–72.PubMed
3.
van Riet YEA, Jansen FH, van Beek M, et al. Localization of non-palpable breast cancer using a radiolabelled titanium seed. Br J Surg. 2010;97:1240–5.PubMedCrossRef
4.
Liberman L, Kaplan J, Van Zee KJ, et al. Bracketing wires for preoperative breast needle localization. AJR. 2001;177:565–72.PubMedCrossRef
5.
Guenin MA. Clip placement during sonographically guided large-core breast biopsy for mammographic-sonographic correlation. AJR. 2000;175:1053–5.PubMedCrossRef
6.
Malvica RP. Sonographic location of the elusive breast lesion: a technical aid to stereotaxic large-needle core biopsy. AJR. 1996;167:183–4.PubMedCrossRef
7.
Oh JL, Nguyen G, Whitman GJ, et al. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer. 2007;110:2420–7.PubMedCrossRef
8.
Edeiken BS, Fornage BD, Bedi DG, et al. US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy. Radiology. 1999;213:895–900.PubMedCrossRef
9.
Kruger BM, Burrowes P, MacGregor JH. Accuracy of marker clip placement after mammotome breast biopsy. Can Assoc Radiol J. 2002;53:137–40.PubMed
10.
Jakub JW, Gray RJ, Degnim AC, et al. Current status of radioactive seed for localization of non palpable breast lesions. Am J Surg. 2010;199:522–8.PubMedCrossRef
11.
Van der ploeg I, Hobbelink M, Vandenbosch M, et al. Radioguided occult lesion localisation (ROLL) for non-palpable breast lesions: a review of the relevant literature. Eur J Surg Oncol. 2008;34:1–5.PubMedCrossRef
12.
Lovrics PJ, Cornacchi SD, Vora R, et al. Systematic review of radioguided surgery for non-palpable breast cancer. Eur J Surg Oncol. 2011;37:388–97.PubMedCrossRef
13.
Genson CC, Blane CE, Helvie MA, et al. Effects on breast MRI of artifacts caused by metallic tissue marker clips. AJR. 2007;188:372–6.PubMedCrossRef
14.
Solin LJ, Yeh I, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatment. Cancer. 1993;71:2532–42.PubMedCrossRef
15.
Parker SH, Lovin JD, Jobe WE, et al. Stereotactic breast biopsy with a biopsy gun. Radiology. 1990;176:741–7.PubMedCrossRef
16.
Weber WN, Sickles EA, Callen PW, et al. Nonpalpable breast lesion localization: limited efficacy of sonography. Radiology. 1985;155:783–4.PubMedCrossRef
17.
Caruso M, Gabrieli G, Marzullo G, et al. Core biopsy as alternative to fine-needle aspiration biopsy in diagnosis of breast tumors. Oncologist. 1998;3:45–9.PubMed
18.
Roux S, Logan-Young W. Private practice interdisciplinary breast centers: their rationale and impact on patients, physicians, and the health care industry: a bicoastal perspective. Surg Oncol Clin North Am. 2000;9:177–98.
19.
Ross RJ, Thompson JS, Kim K, et al. Nuclear magnetic resonance imaging and evaluation of human breast tissue: preliminary clinical trials. Radiology. 1982;143:195–205.PubMedCrossRef
20.
Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220:13–30.PubMedCrossRef
21.
Philpotts LE, Lee CH. Clip migration after 11-gauge vacuum-assisted stereotactic biopsy: case report. Radiology. 2002;222:794–6.PubMedCrossRef
22.
Rosen EL, Vo TT. Metallic clip deployment during stereotactic breast biopsy: retrospective analysis. Radiology. 2001;218:510–6.PubMedCrossRef
23.
Perlet C, Sittek H, Reiser M, et al. Clip marker placement following MR-guided vacuum biopsy of the breast. Radiologe. 2005;45:230–6.PubMedCrossRef
24.
Kubota K, Gomi N, Wakita T, et al. Magnetic resonance imaging of the metal clip in a breast: safety and its availability as a negative marker. Breast Cancer. 2004;11:55–9.PubMedCrossRef
25.
Gossmann A, Bangard C, Warm M, et al. Real-time MR-guided wire localization of breast lesions by using an open 1.0-T imager: initial experience. Radiology. 2008;247:535–42.PubMedCrossRef
26.
Wolf G, Helbich T. Results of stereotactic guidance of breast excisional biopsy versus stereotactic core biopsy in occult breast lesions. Wien Med Wochenschr. 1998;148:316–20.PubMed
27.
Montrey J, Levy J, Brenner R. Wire fragments after needle localization. AJR. 1996;167:1267–9.PubMedCrossRef
28.
Bronstein AD, Kilcoyne RF, Moe RE. Complications of needle localization of foreign bodies and nonpalpable breast lesions. Arch Surg. 1988;123:775–9.PubMedCrossRef
29.
Intra M, Cicco C, Gentilini O, et al. Radioguided localisation (ROLL) of non-palpable breast lesions and simultaneous sentinel lymph node biopsy (SNOLL): the experience of the European Institute of Oncology. Eur J Nucl Med Mol Imaging. 2007;34:957–8.PubMedCrossRef
30.
Rose A, Collins JP, Neerhut P, et al. Carbon localisation of impalpable breast lesions. Breast. 2003;12:264–9.PubMedCrossRef
31.
Baron LF, Baron PL, Ackerman SJ, et al. Sonographically guided clip placement facilitates localization of breast cancer after neoadjuvant chemotherapy. AJR. 2000;174:539–40.PubMedCrossRef
32.
Dash N, Chafin SH, Johnson RR, et al. Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer. AJR. 1999;173:911–7.PubMedCrossRef
33.
Mariscal Martinez A, Sola M, de Tudela AP, et al. Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy. AJR. 2009;193:1001–9.PubMedCrossRef
34.
Luini A, Zurrida S, Paganelli G, et al. Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg. 1999;86:522–5.PubMedCrossRef
35.
Medina-Franco H, Abarca-Prez L, Garca-Alvarez MN, et al. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation. J Surg Oncol. 2008;97:108–11.PubMedCrossRef
36.
Aydogan F, Ozben V, Celik V, et al. Radio-guided occult lesion localization (ROLL) for non-palpable breast cancer: a comparison between day-before and same-day protocols. Breast. 2010;19:226–30.PubMedCrossRef
37.
Nadeem R, Chagla LS, Harris O, et al. Occult breast lesions: a comparison between radioguided occult lesion localisation (ROLL) vs. wire-guided lumpectomy (WGL). Breast. 2005;14:283–9.PubMedCrossRef
38.
Rao R, Moldrem A, Sarode V, et al. Experience with seed localization for nonpalpable breast lesions in a public health care system. Ann Surg Oncol. 2010;17:3241–6.PubMedCrossRef
39.
Svane G. A stereotaxic technique for preoperative marking of non-palpable breast lesions. Acta Radiol. 1983;24:145–51.
40.
Canavese G, Catturich A, Vecchio C, et al. Pre-operative localization of non-palpable lesions in breast cancer by charcoal suspension. Eur J Surg Oncol. 1995;21:47–9.PubMedCrossRef
41.
Mazy S, Galant C, Berlire M, et al. Localization of non-palpable breast lesions with black carbon powder (experience of the Catholic University of Louvain). J Radiol. 2001;82:161–4.PubMed
42.
Parikh JR. Delayed migration of gel mark ultra clip within 15 days of 11-gauge vacuum-assisted stereotactic breast biopsy. AJR. 2005;185:203–6.PubMedCrossRef
43.
Rosen EL, Baker JA, Soo MS. Accuracy of a collagen-plug biopsy site marking device deployed after stereotactic core needle breast biopsy. AJR. 2003;181:1295–9.PubMedCrossRef
44.
Kass R, Kumar G, Klimberg VS, et al. Clip migration in stereotactic biopsy. Am J Surg. 2002;184:325–31.PubMedCrossRef
45.
Uematsu T, Kasami M, Takahashi K, et al. Clip placement after an 11-gauge vacuum-assisted stereotactic breast biopsy: correlation between breast thickness and clip movement. Breast Cancer. 2011 (Epub ahead of print).
46.
Burbank F, Forcier N. Tissue marking clip for stereotactic breast biopsy: initial placement accuracy, long-term stability, and usefulness as a guide for wire localization. Radiology. 1997;205:407–15.PubMedCrossRef
47.
Esserman LE, Cura MA, DaCosta D. Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy. RadioGraphics. 2004;24:147–56.PubMedCrossRef
48.
Harris AT. Clip migration within 8 days of 11-gauge vacuum-assisted stereotactic breast biopsy: case report. Radiology. 2003;228:552–4.PubMedCrossRef
49.
Cho KR, Seo BK, Lee J, et al. A comparative study of palpable and nonpalpable breast cancers determined by ultrasonography. J Breast Cancer. 2008;11:64–70.CrossRef
50.
Berg WA, Gutierrez L, Nessaiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830–49.PubMedCrossRef
51.
Londero V, Zuiani C, Furlan A, et al. Role of ultrasound and sonographically guided core biopsy in the diagnostic evaluation of ductal carcinoma in situ (DCIS) of the breast. Radiol Med. 2007;112:863–76.PubMedCrossRef
52.
Bassett L, Liu T, Giuliano A, et al. The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions. AJR. 1991;157:21–4.PubMedCrossRef
53.
Barros ACSD, Barros MAC, Andrade FE, et al. Combined radioguided nonpalpable lesion localization and sentinel lymph node biopsy for early breast carcinoma. Ann Surg Oncol. 2007;14:1472–7.PubMedCrossRef
54.
Chen B, Liu C, Jin F, et al. The role of fine-wire localization breast biopsy in the management of BI-RADS category 3–5 non-palpable breast lesions in northeastern Chinese women. Health. 2010;2:291–4.CrossRef
55.
Chen X, Lehman CD, Dee KE. MRI-guided breast biopsy: clinical experience with 14-gauge stainless steel core biopsy needle. AJR. 2004;182:1075–80.PubMedCrossRef
56.
Gisvold JJ, Martin JK. Prebiopsy localization of nonpalpable breast lesions. AJR. 1984;143:477–81.PubMedCrossRef
57.
Landheer ML, Veltman J, van Eekeren R, et al. MRI-guided preoperative wire localization of nonpalpable breast lesions. Clin Imaging. 2006;30:229–33.PubMedCrossRef
58.
Ng CH, Lee KT, Taib NA, et al. Experience with hookwire localisation excision biopsy at a medical centre in Malaysia. Singapore Med J. 2010;51:306–10.PubMed
59.
Lehman CD, Shook JE. Position of clip placement after vacuum-assisted breast biopsy: is a unilateral two-view postbiopsy mammogram necessary? Breast J. 2003;9:272–6.PubMedCrossRef
60.
Liberman L, Bracero N, Morris E, et al. MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience. AJR. 2005;185:183–93.PubMedCrossRef
61.
Phillips SW, Gabriel H, Comstock CE, et al. Sonographically guided metallic clip placement after core needle biopsy of the breast. AJR. 2000;175:1353–5.PubMedCrossRef
62.
Chadwick DR, Shorthouse AJ. Wire-directed localization biopsy of the breast: an audit of results and analysis of factors influencing therapeutic value in the treatment of breast cancer. Eur J Surg Oncol. 1997;23:128–33.PubMedCrossRef
63.
Allen MJ, Thompson WD, Stuart RC, et al. Management of non-palpable breast lesions detected mammographically. Br J Surg. 1994;81:543–5.PubMedCrossRef
64.
Gray RJ, Pockaj BA, Karstaedt PJ, et al. Radioactive seed localization of nonpalpable breast lesions is better than wire localization. Am J Surg. 2004;188:377–80.PubMedCrossRef
65.
Moss HA, Barter SJ, Nayagam M, et al. The use of carbon suspension as an adjunct to wire localisation of impalpable breast lesions. Clin Radiol. 2002;57:937–44.PubMedCrossRef
66.
Arman A, Kilicoglu G, Guner HH, et al. Marking of nonpalpable breast lesions using a custom carbon suspension. Acta Radiol. 2001;42:599–601.PubMedCrossRef
67.
Chen X, Lehman CD, Dee KE. MRI-guided breast biopsy: clinical experience with 14-gauge stainless steel core biopsy needle. AJR. 2004;182:1075–80.PubMedCrossRef
68.
Thind C, Desmond S, Harris O, et al. Radio-guided localization of clinically occult breast lesions (ROLL): a DGH experience. Clin Radiol. 2005;60:681–6.PubMedCrossRef
69.
Ronka R, Krogerus L, Leppnen E, et al. Radio-guided occult lesion localization in patients undergoing breast-conserving surgery and sentinel node biopsy. Am J Surg. 2004;187:491–6.PubMedCrossRef
70.
Zgajnar J, Hocevar M, Frkovic-Grazio S, et al. Radioguided occult lesion localization (ROLL) of the nonpalpable breast lesions. Neoplasma. 2004;51:385–9.PubMed
71.
Gray RJ, Salud C, Nguyen K, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001;8:711–5.PubMedCrossRef
72.
Riedl CC, Pfarl G, Helbich TH, et al. Comparison of wire versus carbon localization of non-palpable breast lesions. RöFo. 2002;174:1126–31.PubMed
73.
Moreno M, Wiltgen JE, Bodanese B, et al. Radioguided breast surgery for occult lesion localization—correlation between two methods. J Exp Clin Cancer Res. 2008;27:29.PubMedCentralPubMedCrossRef
74.
Rampaul RS, Bagnall M, Burrell H, et al. Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br J Surg. 2004;91:1575–7.PubMedCrossRef
75.
Hughes JH, Mason MC, Gray RJ, et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J. 2008;14:153–7.PubMedCrossRef
76.
Belloni E, Canevari C, Panizza P, et al. Nonpalpable breast lesions: preoperative radiological guidance in radioguided occult lesion localisation (ROLL). Radiol med. 2011;116(4):564–74.PubMedCrossRef
77.
Smathers RL. Marking the cavity site after stereotactic core needle breast biopsy. AJR. 2003;180:355–6.PubMedCrossRef
78.
Parker SH, Kaske TI, Gerharter JE, Dennis MA, Chavez JL. Placement accuracy and ultrasonographic visualization of a new percutaneous breast biopsy marker. Radiology. 2001;221(P):431.
79.
Esserman LE, Costa D, Kusnick CA, Lowers K. Placement of a new ultrasound (US) visible breast biopsy marker in US-guided 11 gauge directional vacuum assisted biopsy (DVAB) (abstr). Radiology. 2002;25(P):459.
80.
Margolin FR, Kaufman L, Denny SR, et al. Metallic marker placement after stereotactic core biopsy of breast calcifications: comparison of two clips and deployment techniques. AJR. 2003;181:1685–90.PubMedCrossRef
81.
Liberman L, Hann LE, Dershaw DD, et al. Mammographic findings after stereotactic 14-gauge vacuum biopsy. Radiology. 1997;203:343–7.PubMedCrossRef
82.
Coles CE, Wilson CB, Cumming J, et al. Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: audit on behalf of the IMPORT Trial Management Group. Eur J Surg Oncol. 2009;35:578–82.PubMedCrossRef
83.
Feggi L, Basaglia E, Corcione S, et al. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation. Eur J Nucl Med. 2001;28(11):1589–96.PubMedCrossRef
84.
Cornfield J. A method for estimating comparative rates from clinical data. Applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst. 1951;11:1269–75.PubMed
Metadaten
Titel
Procedures for location of non-palpable breast lesions: a systematic review for the radiologist
verfasst von
Roberta Fusco
Antonella Petrillo
Orlando Catalano
Mario Sansone
Vincenza Granata
Salvatore Filice
Massimiliano D’Aiuto
Quentin Pankhurst
Michael Douek
Publikationsdatum
01.09.2014
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 5/2014
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-012-0427-1

Weitere Artikel der Ausgabe 5/2014

Breast Cancer 5/2014 Zur Ausgabe

Case Report

Clinicopathological features of gastric metastasis from breast cancer in three cases

Original Article

Effect of progesterone receptor status on maspin synthesis via nitric oxide production in neutrophils in human breast cancer

Case Report

Sentinel lymph node biopsy in breast cancer patients with previous breast augmentation surgery

Review Article

Functional significance of long non-coding RNAs in breast cancer

Original Article

Reliability of frozen section in breast sentinel lymph node examination

Original Article

Gene delivery of cyclin-dependent kinase inhibitors p21 Waf1 and p27 Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro

Neu im Fachgebiet Onkologie

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

21.05.2024 Krebsvorsorge in der Gynäkologie Nachrichten

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise